DRAP
The new article describes in detail the regulatory approach to be followed when reviewing the applications related to clinical investigations to be conducted in Pakistan.
DRAP
The new article highlights the critical points related to the application process, outlining the key steps to be taken when applying for approval in a clinical investigation.
DRAP
The new article describes in detail the key responsibilities of the parties involved in clinical research.
DRAP
The article provides a general overview of Pakistan’s regulatory requirements for clinical research.
EU
The article provides a general overview of a vigilance system applicable to CE-marked medical devices intended to be marketed and used in the EU and also highlights certain specific aspects associated thereto.
